LogoThe NeuroCircuit
About me
Subscribe

Gene & Cell Therapies in Neurotech

CRISPR, stem cell, and engineered immune-based approaches targeting neurological and neurodegenerative diseases.

Neurotechnology

+5

Weekly Signal: 36 | ALS Trials Accelerate, Ultrasound Advances, MRI Goes Bedside

Dec 6, 2025

•

7 min read

Weekly Signal: 36 | ALS Trials Accelerate, Ultrasound Advances, MRI Goes Bedside

Critical milestones in modern neurotech

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 28 | Neural Interfaces Meet Empathy and Expansion

Oct 11, 2025

•

7 min read

Weekly Signal: 28 | Neural Interfaces Meet Empathy and Expansion

From Parkinson’s progress to pain-sharing tech

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 26 |Gene Therapy, HD-EEG, and Neural Rights

Sep 27, 2025

•

6 min read

Weekly Signal: 26 |Gene Therapy, HD-EEG, and Neural Rights

Clinical, industry, and policy signals

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+3

Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone 🧠

Aug 16, 2025

•

6 min read

Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone 🧠

BCI, industry moves, and neural privacy—this week’s signals.

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal 15: Restoring Minds, Reshaping Rights

Jul 14, 2025

•

6 min read

Weekly Signal 15: Restoring Minds, Reshaping Rights

Cell therapies, real-time BCI speech, and mental privacy battles.

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+8

Weekly Signal: 04

Apr 25, 2025

•

9 min read

Weekly Signal: 04

Unlocking the Brain: Breakthroughs in Hearing, Healing, and Mobility

Ricardo Albornoz
Ricardo Albornoz
The NeuroCircuit

The NeuroCircuit

The weekly briefing for people building the future of the brain.


FAQs

NeuroCircuit

© 2026 The NeuroCircuit.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv